Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL).
Phase of Trial: Phase II
Latest Information Update: 20 Jan 2012
At a glance
- Drugs Forodesine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 20 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2011 Planned end date changed from 1 Jun 2011 to 1 Nov 2011 as reported by ClinicalTrials.gov.